CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Truist Raises Price Target on Sabra Health Care REIT to $24 From $22, Keeps Buy Rating

Positive
AI Analysis

Summary

Truist raised its price target on Sabra Health Care REIT from $22 to $24 while maintaining a Buy rating.

Importance:2/10
Sentiment:
0.40
price_target_increaseequity_researchreit
Related Companies

Read the original article

Published by yahoo_finance on July 22, 2026 11:44 AM

Read Original